Quenching effect of deferoxamine on free radical-mediated photon production in luminol and ortho-phenanthroline-dependent chemiluminescence

Mahdi Parvar Jalil Mehrzad Mohammad Javad Chaichi Saman Hosseinkhani Hamid Golchoubian

Citation:  Mahdi Parvar, Jalil Mehrzad, Mohammad Javad Chaichi, Saman Hosseinkhani, Hamid Golchoubian. Quenching effect of deferoxamine on free radical-mediated photon production in luminol and ortho-phenanthroline-dependent chemiluminescence[J]. Chinese Chemical Letters, 2014, 25(4): 630-634. doi: 10.1016/j.cclet.2014.01.022 shu

Quenching effect of deferoxamine on free radical-mediated photon production in luminol and ortho-phenanthroline-dependent chemiluminescence

    通讯作者: Jalil Mehrzad,
  • 基金项目:

    The authors gratefully acknowledge the bureau (area) for research  (area)

摘要: Removing excessive free radicals (FRs) by a synthetic chemical might give a clue for treatment of many iron-mediated diseases. Deferoxamine (DFO) can be one of the chemicals of choice for the clue. To investigate photoredox properties of DFO, its quenching effect on superoxide radical (O2), hydrogen peroxide (H2O2) and hydroxyl radical (OH·) was examined using luminol and ortho-phenanthroline (o-phen) chemiluminescence (CL) systems and UV-vis spectrophotometry. Stern-Volmer equation was also used for the CL kinetics. The observed quenching effect of DFO on CL/photon production in luminol and o-phen CL systems strongly confirmed the static arm of quenching properties of DFO on OH· and H2O2, but much less pronounced on O2; the quenching property wasmaximal when iron was involved in the reaction systems. The Stern-Volmer plots in the designed photochemical reaction systems also confirmed a potent quenching effect of DFO on FR-mediated CL. Our study highlights strong photoreducing and antioxidant properties of DFO with huge quenching capacity on excessive FRs, and thus implies its promising prospects for therapeutic applications.

English

  • 
    1. [1] J. Mehrzad, H. Dosogne, E. Meyer, R. Heyneman, C. Burvenich, Respiratory burst activity of blood and milk neutrophils in dairy cows during different stages of lactation, J. Dairy Res. 68 (2001) 399-415.[1] J. Mehrzad, H. Dosogne, E. Meyer, R. Heyneman, C. Burvenich, Respiratory burst activity of blood and milk neutrophils in dairy cows during different stages of lactation, J. Dairy Res. 68 (2001) 399-415.

    2. [2] J. Mehrzad, L. Duchateau, C. Burvenich, High milk neutrophil chemiluminescence limits the severity of bovine coliform mastitis, Vet. Res. 36 (2005) 101-116.[2] J. Mehrzad, L. Duchateau, C. Burvenich, High milk neutrophil chemiluminescence limits the severity of bovine coliform mastitis, Vet. Res. 36 (2005) 101-116.

    3. [3] S. Dikalov, K.K. Griendling, D.G. Harrison, Measurement of reactive oxygen species in cardiovascular studies, Hypertension 49 (2007) 717-727.[3] S. Dikalov, K.K. Griendling, D.G. Harrison, Measurement of reactive oxygen species in cardiovascular studies, Hypertension 49 (2007) 717-727.

    4. [4] K. Takeshige, S. Minakami, NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation, Biochem. J. 180 (1979) 129-135.[4] K. Takeshige, S. Minakami, NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation, Biochem. J. 180 (1979) 129-135.

    5. [5] B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol. 186 (1990) 1-85.[5] B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol. 186 (1990) 1-85.

    6. [6] C.W. Trenam, D.R. Blake, C.J. Morris, Skin inflammation: reactive oxygen species and the role of iron, J. Invest. Dermatol. 99 (1992) 675-682.[6] C.W. Trenam, D.R. Blake, C.J. Morris, Skin inflammation: reactive oxygen species and the role of iron, J. Invest. Dermatol. 99 (1992) 675-682.

    7. [7] G. Poli, U. Leonarduzzi, F. Biasi, E. Chiarpotto, Oxidative stress and cell signaling, Curr. Med. Chem. 11 (2004) 1163-1182.[7] G. Poli, U. Leonarduzzi, F. Biasi, E. Chiarpotto, Oxidative stress and cell signaling, Curr. Med. Chem. 11 (2004) 1163-1182.

    8. [8] J.E. Schneider, M.M. Browning, X. Zhu, K.L. Eneff, R.A. Floyd, Characterization of hydroxyl free radical mediated damage to plasmid pBR322 DNA, Mutat. Res. 214 (1989) 23-31.[8] J.E. Schneider, M.M. Browning, X. Zhu, K.L. Eneff, R.A. Floyd, Characterization of hydroxyl free radical mediated damage to plasmid pBR322 DNA, Mutat. Res. 214 (1989) 23-31.

    9. [9] E.R. Stadtman, B.S. Berlett, Reactive-oxygen mediated protein oxidation in aging and disease, Chem. Res. Toxicol. 10 (1997) 485-494.[9] E.R. Stadtman, B.S. Berlett, Reactive-oxygen mediated protein oxidation in aging and disease, Chem. Res. Toxicol. 10 (1997) 485-494.

    10. [10] H.J.H. Fenton, Oxidation of tartaric acid in the presence of iron, J. Chem. Soc. 65 (1894) 899-910.[10] H.J.H. Fenton, Oxidation of tartaric acid in the presence of iron, J. Chem. Soc. 65 (1894) 899-910.

    11. [11] E. Neyens, J. Baeyens, A review of classic Fenton's peroxidation as an advanced oxidation technique, J. Hazard. Mater. 98 (2003) 33-50.[11] E. Neyens, J. Baeyens, A review of classic Fenton's peroxidation as an advanced oxidation technique, J. Hazard. Mater. 98 (2003) 33-50.

    12. [12] S.B. Wang, A comparative study of Fenton and Fenton-like reaction kinetics in decolourisation of wastewater, Dyes Pigments 76 (2008) 714-720.[12] S.B. Wang, A comparative study of Fenton and Fenton-like reaction kinetics in decolourisation of wastewater, Dyes Pigments 76 (2008) 714-720.

    13. [13] F. Haber, J. Weiss, The catalytic decomposition of hydrogen peroxide by iron salts, Proc. R. Soc. Lond. A 147 (1934) 332-351.[13] F. Haber, J. Weiss, The catalytic decomposition of hydrogen peroxide by iron salts, Proc. R. Soc. Lond. A 147 (1934) 332-351.

    14. [14] B. Halliwell, Free-radicals, antioxidants, and human disease: curiosity, cause, or consequences, Lancet 344 (1994) 721-724.[14] B. Halliwell, Free-radicals, antioxidants, and human disease: curiosity, cause, or consequences, Lancet 344 (1994) 721-724.

    15. [15] M. Auer, L.A. Pfister, D. Leppert, M.G. Taüber, S.L. Leib, Effects of clinically used antioxidants in experimental pneumococcal meningitis, J. Infect. Dis. 182 (2000) 347-350.[15] M. Auer, L.A. Pfister, D. Leppert, M.G. Taüber, S.L. Leib, Effects of clinically used antioxidants in experimental pneumococcal meningitis, J. Infect. Dis. 182 (2000) 347-350.

    16. [16] I. Paterniti, E. Mazzon, E. Emanuela, et al., Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator, Free Radic. Res. 44 (2010) 694-699.[16] I. Paterniti, E. Mazzon, E. Emanuela, et al., Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator, Free Radic. Res. 44 (2010) 694-699.

    17. [17] E.M. Hoke, C.A. Maylock, E. Shacter, Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin, Free Radic. Biol. Med. 39 (2005) 403-411.[17] E.M. Hoke, C.A. Maylock, E. Shacter, Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin, Free Radic. Biol. Med. 39 (2005) 403-411.

    18. [18] E. Banin, A. Lozinski, K.M. Brady, et al., The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16761-16766.[18] E. Banin, A. Lozinski, K.M. Brady, et al., The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16761-16766.

    19. [19] C.L. Tielemans, C.M. Lenclud, R. Wens, F.E. Collart, M. Dratwa, Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine, Nephrol. Dial. Transplant. 4 (1989) 883-887.[19] C.L. Tielemans, C.M. Lenclud, R. Wens, F.E. Collart, M. Dratwa, Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine, Nephrol. Dial. Transplant. 4 (1989) 883-887.

    20. [20] O. Cozar, N. Leopold, C. Jelic, et al., IR, Raman and surface-enhanced Raman study of desferrioxamine B and its Fe(ⅡI) complex, ferrioxamine B, J. Mol. Struct. 788 (2006) 1-6.[20] O. Cozar, N. Leopold, C. Jelic, et al., IR, Raman and surface-enhanced Raman study of desferrioxamine B and its Fe(ⅡI) complex, ferrioxamine B, J. Mol. Struct. 788 (2006) 1-6.

    21. [21] S. Singh, R.C. Hider, J.B. Porter, Separation and identification of desferrioxamine and its iron chelating metabolites by high performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluids, Anal. Biochem. 187 (1990) 212-219.[21] S. Singh, R.C. Hider, J.B. Porter, Separation and identification of desferrioxamine and its iron chelating metabolites by high performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluids, Anal. Biochem. 187 (1990) 212-219.

    22. [22] E. Farkas, H. Csóka, G. Micera, A. Dessi, Copper(Ⅱ), nickel(Ⅱ), zinc(Ⅱ), and molybdenum( VI) complexes of desferrioxamine B in aqueous solution, J. Inorg. Biochem. 65 (1997) 281-286.[22] E. Farkas, H. Csóka, G. Micera, A. Dessi, Copper(Ⅱ), nickel(Ⅱ), zinc(Ⅱ), and molybdenum( VI) complexes of desferrioxamine B in aqueous solution, J. Inorg. Biochem. 65 (1997) 281-286.

    23. [23] I. Parejo, C. Petrakis, P. Kefalas, A transition metal enhanced luminol chemiluminescence in the presence of a chelator, J. Pharmacol. Toxicol. 43 (2000) 183-190.[23] I. Parejo, C. Petrakis, P. Kefalas, A transition metal enhanced luminol chemiluminescence in the presence of a chelator, J. Pharmacol. Toxicol. 43 (2000) 183-190.

    24. [24] M. Shamsipur, M.J. Chaichi, A study of quenching effect of sulfur-containing amino acids L-cysteine and L-methionine on peroxyoxalate chemiluminescence of 7-amino-4-trifluoromethylcumarin, Spectrochim. Acta A: Mol. Biomol. Spectrosc. 61 (2005) 1227-1231.[24] M. Shamsipur, M.J. Chaichi, A study of quenching effect of sulfur-containing amino acids L-cysteine and L-methionine on peroxyoxalate chemiluminescence of 7-amino-4-trifluoromethylcumarin, Spectrochim. Acta A: Mol. Biomol. Spectrosc. 61 (2005) 1227-1231.

    25. [25] Y.J. Hua, I. Narumi, G.J. Gao, et al., PprI: a general switch responsible for extreme radioresistance of Deinococcus radiodurans, Biochem. Biophys. Res. Commun. 306 (2003) 354-360.[25] Y.J. Hua, I. Narumi, G.J. Gao, et al., PprI: a general switch responsible for extreme radioresistance of Deinococcus radiodurans, Biochem. Biophys. Res. Commun. 306 (2003) 354-360.

    26. [26] B. Tian, Y. Wu, D. Sheng, et al., Chemiluminescence assay for reactive oxygen species scavenging activities and inhibition on oxidative damage of DNA in Deinococcus radiodurans, Luminescence 19 (2004) 78-84.[26] B. Tian, Y. Wu, D. Sheng, et al., Chemiluminescence assay for reactive oxygen species scavenging activities and inhibition on oxidative damage of DNA in Deinococcus radiodurans, Luminescence 19 (2004) 78-84.

    27. [27] Y. Zhao, W. Yu, D. Wang, X. Liang, T. Hu, Chemiluminescence determination of free radical scavenging abilities of ‘tea pigments' and comparison with ‘tea polyphenols', Food Chem. 80 (2003) 115-118.[27] Y. Zhao, W. Yu, D. Wang, X. Liang, T. Hu, Chemiluminescence determination of free radical scavenging abilities of ‘tea pigments' and comparison with ‘tea polyphenols', Food Chem. 80 (2003) 115-118.

    28. [28] C. Xiao, D.A. Palmer, D.J. Wesolowski, S.B. Lovitz, W. King, Carbon dioxide effects on luminol and 1,10-phenanthroline chemiluminescence, Anal. Chem. 74 (2002) 2210-2216.[28] C. Xiao, D.A. Palmer, D.J. Wesolowski, S.B. Lovitz, W. King, Carbon dioxide effects on luminol and 1,10-phenanthroline chemiluminescence, Anal. Chem. 74 (2002) 2210-2216.

    29. [29] L. Magnania, E.M. Gaydoua, J.C. Hubaud, Spectrophotometric measurement of antioxidant properties of flavones and flavonols against superoxide anion, Anal. Chim. Acta 411 (2000) 209-216.[29] L. Magnania, E.M. Gaydoua, J.C. Hubaud, Spectrophotometric measurement of antioxidant properties of flavones and flavonols against superoxide anion, Anal. Chim. Acta 411 (2000) 209-216.

    30. [30] T. Sun, Z.D. Xu, Radical scavenging activities of a-alanine C60 adduct, Bioorg. Med. Chem. Lett. 16 (2006) 3731-3734.[30] T. Sun, Z.D. Xu, Radical scavenging activities of a-alanine C60 adduct, Bioorg. Med. Chem. Lett. 16 (2006) 3731-3734.

  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  1530
  • HTML全文浏览量:  66
文章相关
  • 发布日期:  2014-01-14
  • 收稿日期:  2013-07-19
  • 网络出版日期:  2013-12-24
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章